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In nature, interfacial molecular interactions are at the heart of all biological processes that are 10 
greatly mediated by a diversity of stimuli. Inspired by natural molecular responsive mechanisms and 11 
our increased capability to manipulate matter at molecular level, a new generation of bio-interface 12 
materials is being developed that possess responsiveness towards various external stimuli. In this 13 
review, we discuss emerging methods for imparting surfaces with dynamic properties and how these 14 
in turn are introducing increased functional complexity at the bio-interface. We examine how recent 15 
advances are becoming important in providing new insights on cell behaviour, allowing progress in 16 
the regenerative medicine and tissue engineering fields, providing new opportunities to address the 17 
intricate issues associated with biofouling and opening the door to on-demand sensing devices and 18 
highly effective delivery, bioseparation and bioelectrocatalytic systems. Although progress is being 19 
made, the review also highlights that current methods are still limited in their capability to impart 20 
complex functionality onto the bio-interface to fully address the current challenges in biotechnology 21 
and biomedicine. Exciting prospects include incorporation at the bio-interface of full reversibility of 22 
interactions, a broad repertoire of multi-responsiveness and bidirectional actuation as well as the 23 
capability to implement developed systems into practical use. 24 
 25 
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1. Introduction 26 
 27 
Nature has been a permanent creative source of inspiration for conceiving novel synthetic 28 
materials with tailored properties and functions. From the development of nylon to mimic the 29 
functionality of silk and the invention of Velcro inspired by the burrs of plants to the more recent 30 
advances on synthetic gecko-inspired adhesives and lotus leaf-inspired self-cleaning materials, the 31 
structure, form and function of nature materials are being emulated to create a wide-range of high-32 
performance materials for the benefit of human beings. With living organisms exhibiting the 33 
prevalent characteristic of responding to a multitude of stimuli (including temperature, pH, 34 
chemicals, pressure, magnetic and electric fields), an invaluable source of examples exists for us to 35 
hold on to develop materials with stimuli-responsive properties. Indeed, the search for improved 36 
functionalities to meet current needs has led to the introduction of the concepts of stimuli-37 
responsiveness borrowed from biological systems into synthetic materials. In this context, active and 38 
switchable bio-interfaces have made rapid advances in recent years due to their relevance in many 39 
biotechnological and biomedical applications.1, 2 It includes their use to understand and control 40 
mammalian3, 4 and bacterial cells, 5, 6 as dynamic tools for bioseparation,7 biosensing8 and 41 
bioelectrocalatysis9 and as responsive nanomaterials for cancer therapy,10, 11 and smart cancer 42 
theranostics.12 43 
The creation of stimuli-responsive interfaces between synthetic materials and biological 44 
systems is providing the unprecedented ability to modulate biomolecular interactions, emulating, 45 
thus, aspects of the transient interactions that are central to all biological processes, including signal 46 
transduction, cell differentiation, enzyme catalysis and inhibition and DNA replication and 47 
transcription.13, 14 These transient interactions, which can involve, for instance, protein-protein, 48 
protein-ligand, protein-DNA interactions, are initiated by a broad variety of chemical and physical 49 
stimuli and can comprise intracellular relocalizations, chemical modifications and structural 50 
rearrangements.15 Several new techniques have recently emerged for deciphering mechanistic 51 
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details of these dynamic transient interactions, comprising in vivo and in vitro studies.16-18 The 52 
increased knowledge brought up by these studies, together with the emerging advances on 53 
controlling biomolecular interactions, can open important prospects in the development of 54 
advanced discovery tools for identification of targets suitable for therapeutic intervention in a broad 55 
range of disease conditions. 56 
With the increased experimental capability to manipulate and characterize matter at the 57 
molecular level, and concomitant advances in molecular modelling and simulations, stimuli-58 
responsive mechanisms are being creatively incorporated into bio-interfaces to dynamically control 59 
their properties and functionalities (Figure 1). Owing to their capability for temporal regulation of 60 
molecular interactions, stimuli-responsive bio-interfaces have been devised to mimic the dynamic 61 
characteristics of the natural extracellular matrix (ECM), leading to new efforts to understand and 62 
control cell behaviour.3, 19 Although the developed strategies remain far from capturing the complex 63 
ECM-cell interactions encountered in vivo, they are providing new insights on how cells respond to 64 
temporal variations in their environment and how they can be manipulated at the bio-interface to 65 
engender desired cellular responses. The latter has important implications on the control of 66 
regenerative processes and repair of damaged tissues. Furthermore, a paradigm shift from static to 67 
dynamic molecular interactions at bio-interfaces is providing an unprecedented opportunity for 68 
developing active bio-interfaces to understand5 and prevent6 bacterial adhesion. Stimuli-responsive 69 
bio-interfaces are also regarded as ideal platforms for on-demand precise drug release inside the 70 
human body20 and sensing platforms with the capability to detect binding events only when 71 
required.8 Incorporation of redox active molecules, such as proteins and enzymes, at the bio-72 
interface, in which their activity can be tuned on-demand upon application of an external stimulus, is 73 
offering new possibilities to modulate electron-transfer processes and bioelectrocatalysis.21  74 
Herein, emerging advances of stimuli-responsive bio-interfaces are reviewed and their role 75 
from tuning molecular interactions to induce the desired response is highlighted. To begin with, we 76 
aim to delve into aspects of stimuli choice, diversity and capability to induce a particular response. 77 
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From there on, the review is primarily organized according to the properties imparted to the bio-78 
interface rather than around the form of stimuli used for their activation. Key achievements and 79 
challenges associated with the development of active, dynamic biointerface materials for 80 
modulating biomolecule capture and release, bioelectrocatalysis, cell behaviour and bacterial 81 
adhesion are discussed. Our aim is that by looking at the field from a functional perspective, we can 82 
bring to light key factors contributing to specific properties on dynamic bio-interfaces and discuss 83 
which hurdles still prevail in terms of harnessing molecular designs, surface molecular tailoring and 84 
switching mechanisms to achieve highly desired functions. At present, advances are largely confined 85 
to academic settings, and in this review we shed light on key design aspects that need to be 86 
considered to drive the emerging developments from the laboratory to the end user. 87 
 88 
 89 
 90 
Figure 1 - Scheme illustrating the broad range of stimuli that have been explored to develop dynamic 91 
biological interfaces for a numerous of biological and medical applications. 92 
 93 
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 94 
2. Stimuli choice, diversity and capabilities 95 
  96 
 Two main paths can be taken for a stimulus to induce changes in the bio-interfacial 97 
interactions between material surfaces and biological systems. One is the stimulus to act on the 98 
biological system,22, 23 whereas the other relies on eliciting a change in the material surface.1, 21 While 99 
both strategies have been demonstrated with success, the latter has been extensively explored since 100 
it affords wider biomedical and biotechnological applicability, while potentially avoiding complex 101 
and time-consuming processes related with the re-engineering of biological systems. The capability 102 
to tune the chemical properties of a surface material depends on an intimate interplay between 103 
molecular composition, arrangement and topography within the first few nanometers of the surface, 104 
and also location and type of stimulus. It is based on such premises that material surfaces have been 105 
developed that can trigger molecular interaction changes at the bio-interface using a wide range of 106 
stimuli. These stimuli include electric potential and field,24 magnetic field,25, 26 mechanical force,6, 27 107 
light,28, 29 temperature,30, 31 pH,32, 33 ionic strength34 and the presence of molecules such as adenosine 108 
triphosphate (ATP),35 carbohydrates36 and enzymes.37, 38 Self-assembled monolayers (SAM),24 109 
polymeric systems,39 molecular imprinting40 and nanopatterning techniques41-43 are proving 110 
instrumental for the rational design of stimuli-responsive surfaces. 111 
With the first developments being focused on single-stimulus responsive property of the 112 
bio-interface, the field has been witnessing a growing interest in the concept of bio-interfaces with 113 
responsiveness to multiple stimuli.44, 9, 45 Although the presence of a bio-interface with single-114 
responsive attributes is well capable of meeting the needs of many biotechnological and biomedical 115 
applications, the possibility of combining two or more stimuli enhances the bio-interface capability, 116 
versatility and applicability while bringing us closer to mimic complex natural systems. Emerging 117 
systems are showing that multi-stimuli-encoded bio-interfaces are able to induce synergetic effects44 118 
and program electrochemical output signals using “OR” and “AND” logic gate concepts.9  119 
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All different stimuli have their own strengths and limitations, and depending on the 120 
applicability of the dynamic bio-interface, some can be more effective than others in triggering a 121 
particular response. Thus, by defining the requirements of the application, the necessary control 122 
over bio-interactions and the environment in which the stimuli-responsive material needs to 123 
perform, identification of the most effective stimulus (or stimuli) for development of a responsive 124 
bio-interface is possible. The stimuli should be non-invasive and can, for instance, be restricted by 125 
the conditions required for normal biological functions. In the design of stimuli-responsive materials 126 
for in vivo drug delivery, one can consider the use of non-invasive endogenous stimulus (e.g. pH or 127 
specific enzymes) but where one needs to address the sensitivity of the system to low cue 128 
concentrations and the capability of the system to deal with fluctuations in the endogenous cues in 129 
different patients. On the other hand, while an external stimulus mitigates such fluctuations, the 130 
strong source intensity (e.g. magnetic field or light) required for system activation in the body 131 
restricts their use in eventual clinical applications. Thus, the judicious selection of stimuli in the 132 
design of stimuli-responsive delivery systems is critical and where we are currently witnessing the 133 
introduction of more advanced non-invasive external stimuli, such as near-infrared (NIR) radiation,46 134 
to address some of the challenges. 135 
In another example, if the purpose is to better understand or control cell behaviour in vitro, 136 
since cells function under a narrow pH and ionic strength range, other stimuli such as temperature,47 137 
electrical potential4 or light28 are more adequate. In certain settings, one can take advantage of 138 
native stimuli provided by cells (i.e. endogenous stimulus), such as cell-secreted enzymes (e.g. matrix 139 
metalloproteinases37 and alkaline phosphatase38) or pH changes due to production of acids resulting 140 
from bacterial metabolism33 to devise cell-responsive bio-interfaces with highly desired autonomous 141 
functionality. Addressability, mode of actuation and spatial control are characteristics associated 142 
with all different stimuli that can be also determinant in the appropriate stimulus selection (Table 1).  143 
 144 
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Table 1 – Addressability, mode of actuation, spatial resolution and switchable entities associated 145 
with a particular stimulus. 146 
Stimulus Addressability Actuation Spatial 
Control 
Examples of switchable entities 
pH Easy Contact No Poly(acrylamide-co-acrylic acid) (P(AAm-
co-AAc))7; Poly(methacrylic acid) 
(PMAA)48 
Temperature Easy 
 
Remote No Poly(N-isopropylacrylamide) (PNIPAM)49 
Mechanical Advanced Remote No Polydimethylsiloxane (PDMS)6 
 
Optical Intermediate Remote Yes O-Nitrobenzyl derivatives50; Spiropyran51; 
Azobenzene52 
Magnetic Advanced Remote Yes Magnetic structures25 and particles26 
Electrical Advanced but with 
multiple individually 
addressability 
Remote Yes - 
Nanoscale 
Hydroquinone–quinone redox couple19; 
Charged molecular entities53; Poly(3,4-
ethylenedioxy thiophene) (PEDOT) 54; 
Polypyrrole (PPy)40 
 147 
Together with other chemical stimuli, the benefits of pH-driven bio-interface changes 148 
include easy addressability and the possibility to directly affect the binding affinity of the surface 149 
material for biomolecules in solution.7  Temperature is also easy to control and apply, but in contrast 150 
with chemical stimuli, it relies on remote actuation, which gives the possibility to tune biomolecular 151 
interactions without altering the solution composition. Temperature-controlled bio-interfaces have 152 
been relying mainly on the reversible, sharp phase transition behaviour of thermo-responsive 153 
polymers, namely PNIPAM.30, 31 Mechanical stimuli, such as stretching and compression, open up the 154 
possibility to induce mechanical movements and reversibly tune geometrical structures of bio-155 
interfaces.6 Local stimulation is generally not possible with chemical, thermal or mechanical stimuli, 156 
and thus if spatial control is required, optical, electrical and magnetic stimuli are able to meet such 157 
demands. While optical stimulus can be considered more convenient than electrical stimulus, the 158 
latter allows for easy creation of multiple individually addressable switchable nanoregions on the 159 
same surface.55 On the other hand, while light as a stimulus is independent on the material used, an 160 
electrical and magnetic stimulus requires an electrically conducting and magnetic substrate material, 161 
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respectively. Irreversible photocleavage of o-nitrobenzyl derivatives50 and reversible photo-triggered 162 
isomerization of spiropyran51 and azobenzene52 moieties are photoreactions commonly used to 163 
achieve photo-switchable bio-interfaces. Electrically responsive surfaces operate generally under 164 
similar trigger-induced modifications as photo-switchable surfaces, where the hydroquinone–165 
quinone redox couple,19 charged molecular backbones53 or end groups56 and conductive polymers, 166 
such as PEDOT,54 feature prominently as the switching units. 167 
 168 
3. Autonomous capabilities 169 
 170 
While most developed stimuli-responsive systems are unidirectional as they require 171 
repetitive on–off switching of external stimuli to induce bidirectional action, non-unidirectional, 172 
autonomous systems are less explored, but may offer unique opportunities as self-beating 173 
pacemakers, drug release systems synchronized with human biorhythms and autonomous mass 174 
transport systems, mimicking, for instance, the capillary blood flow or the intestine-like peristaltic 175 
pumping motion. Self-oscillating polymer gels have been at the centre of such efforts, where the 176 
chemical energy of the Belousov–Zhabotinsky (BZ) reaction is converted into mechanical energy to 177 
generate periodic volume or shape changes. In particular, Yoshida and co-workers50, 51 have 178 
developed a self-oscillating cross-linked gel composed of PNIPAM with covalently bound ruthenium 179 
tris(2,2′-bipyridine) (Ru(bpy)3) as the BZ catalyst. The BZ reaction generates autonomous and 180 
rhythmical redox oscillations from the oxidized Ru(III) state to the reduced Ru(II) state, which 181 
induces a periodic swelling-deswelling of the gel upon its  immersion in an aqueous acidic solution 182 
containing the substrates for the BZ reaction. Recent improvements on the functions of self-183 
oscillating polymer systems ranges from enhanced - but still modest - swelling-deswelling 184 
amplitudes (i.e. in the range of 100 µm)57 and oscillation frequencies (i.e. in the order of 0.5 Hz)58 to 185 
achieving autonomously self-propelled motion,59 autonomous transport,57 and unidirectional control 186 
of self-oscillating waves.60 The emphasis thus far has been on modifications of the internal structure 187 
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of the BZ gels that are expected, together with hierarchical integration, to continue to drive the next 188 
level of complexity and function, such as time-asymmetrical responses or capability to adapt to 189 
external signals. However, if these out-of-equilibrium systems are to progress from proof-of-concept 190 
to biomedical technological solutions, the feedback-controlled systems will need to be designed to 191 
be biocompatible, sustain long lasting stability and operation in biological environments and utilise 192 
substrates at biologically relevant concentrations. 193 
 194 
4. Capture and release of bioactive molecules at the material interface 195 
 196 
4.1. Controlled release for in vivo drug delivery systems 197 
  198 
 One of the most well-demonstrated behaviours in dynamic synthetic surfaces is their 199 
capability to immobilize and/or release bioactive molecules on demand. Indeed, this capability is 200 
embedded in many examples of stimuli-responsive nanoparticles for controlled drug release that are 201 
promising nanoconstructs for theranostics.61 However, it is important to highlight that on 202 
nanoparticle design, not only the incorporation of stimuli-responsive mechanisms needs to be 203 
considered, but also particle size and charge, shape and flexibility since they play a key role in vivo 204 
distribution, stability and targeting ability, and in their toxicity and elimination.62 While significant 205 
progress has been made with respect to nanoparticles capability for drug encapsulation and 206 
responsiveness to various endogenous and exogenous stimuli,63-65 in which pH has been widely 207 
explored as a stimulus, their clinical translation remains challenging. These hurdles are reflected in 208 
the very limited number of stimuli-responsive nanoparticles that have reached clinical trial (e.g. 209 
ThermoDox). One of the key challenges is how to achieve controlled release in vivo with precise  210 
spatiotemporal control. The use of an external stimulus (e.g. temperature, magnetic field, 211 
ultrasound, light or electrical) provides better control to achieve it, but their efficacy has been 212 
hindered by the limited depth of penetration in tissue. These difficulties are starting to be tackled by 213 
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designing nanoparticles that rely on the synergetic effect of endogenous and exogenous stimuli.46 214 
However, in vitro and in vivo studies would be needed to ascertain the clinical viability of such 215 
strategy. Thus, future efforts should be directed at understanding and establishing high efficacy of 216 
stimuli-responsive nanoparticles in vivo and indeed their suitability to be introduced in the human 217 
body (i.e. biodistribution, toxicity, and degradation).66, 67 Nanoparticle features such as robustness 218 
and maximum function, while obeying to minimal design principles, are expected to play key roles in 219 
meeting this challenge. A more extensive discussion on this subject is available elsewhere.68, 69 220 
Capture and release capabilities have been also explored for creating implantable systems 221 
with controlled on-demand release properties. In this setting, an electrical stimulus is highly suited 222 
for externally and precisely controlling the release of therapeutics in the body, and this is reflected in 223 
the considerable focus being given to the development of electro-responsive polymer-based 224 
implantable delivery systems.70, 71  Furthermore, the use of an electrical stimulus allows delivery in 225 
sites of difficult access to other stimuli-responsive delivery systems, namely the brain and the eye. 226 
As an example, by emulating the natural release process of neurotransmitters in the retina, PPy-227 
based molecularly imprinted polymer films have been created for the retinal neurotransmitter 228 
glutamate to chemically stimulate retinal neurons.40  229 
There are several aspects to consider when designing a switchable drug release interface. 230 
The system should be compatible with surrounding tissues, able to accommodate a high drug 231 
loading, have an efficient and highly controllable release process and perform under a diverse 232 
portfolio of drugs. In order to address such requirements, conductive polymers are being recently 233 
integrated with structured surfaces to sustain high drug loading and fabricate high effective 234 
electrochemical surface areas. The latter promotes the speed and extent of ion movement into and 235 
out of the polymer, allowing more precise and higher responsiveness. Three-dimensionally ordered 236 
macroporous PPy inverse opal thin films are shown to enhance drug loading capacity and provide 237 
not only sustained release but also pulsatile release triggered by electrical stimulation.72 The active 238 
release of the drug – corticosteroid hormone - incorporated into the polymer occurs due to a change 239 
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in charge and volume caused by the movement of ions during electrical stimulation. The system 240 
offers the possibility to fine-tune the dosage required, depending on the disease state and patient’s 241 
needs.  With similar proviso in mind, anodized aluminium oxide (AAO) membranes, which exhibit 242 
high density arrays of uniform and parallel nanopores, are able to incorporate large amounts of 243 
drugs for the release during extended periods of time.20 By electropolymerizing PPy doped with 244 
dodecylbenzenesulfonate anions (PPy/DBS) onto the top and upper side wall of the AAO membrane, 245 
the pore of the membrane can be open or closed upon switching of redox states (oxidation vs 246 
reduction), allowing on-off drug release. These and many other examples reported in the literature70, 247 
71 illustrate how, in particular, electro-responsive polymer films can be imparted with controlled and 248 
responsive molecular transporting abilities for tunable implantable delivery systems. However, 249 
endogenous biomolecule interference, biodegradability and efficacy in vivo are still aspects which 250 
need due consideration.  251 
 252 
4.2. In vitro bioseparation systems 253 
 254 
Bioseparation processes, which might entail extraction of proteins, peptides, DNA and 255 
antibodies at low concentration from complex biological fluids, should be conceived taking into 256 
consideration simplicity of operation, cost-effectiveness and performance in mild conditions. Thus, 257 
stimuli-responsive surfaces possess prominent advantages over conventional materials for inclusion 258 
in biomolecule sorting processes typically involving a series of sequential steps. By switching ON and 259 
OFF their affinity for the target molecule, in response to a stimulus, responsive surfaces allow higher 260 
capture and sequential elution of target molecules in organic solvent-free conditions. Furthermore, 261 
stimuli-responsiveness holds the innate merits of easy regeneration and prolonged reusability.  262 
In order to meet the design criterion of simplicity of operation, temperature- and pH-263 
responsive surfaces have been the most widely investigated responsive surfaces for integration in 264 
bioseparation processes by relying mainly on their capability to control hydrophobic and 265 
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electrostatic interactions.73 For instance, a cyclodextrin-grafted pH-responsive poly(ethylene glycol)-266 
block-poly(acrylic acid) immobilised on an azobenzene-terminated SAM is able to reversibly expose a 267 
negative or neutral charge depending on the pH, inducing the capture or release of the positively 268 
charged protein cytochrome c.52 Whereas these systems, which are based on non-specific 269 
interactions, are able to meet some of the bioseparation end uses, the remaining challenge today is 270 
to promote a high degree of selectivity while creating a fully reversible system. In order to achieve 271 
this goal, an ingenious chemomechanical sorting system has been devised to catch and release 272 
target biomolecules from a solution mixture.7 Inspired from the ability of vesicle-carrying kinesins 273 
and dyneins to shuttle different biomolecule cargos along the microtubule network, a microfluidic 274 
system has been built to facilitate a bilayer fluid flow and accommodate bendy pH-responsive 275 
polymeric P(AAm-co-AAc) microscopic fins functionalised with a pH-sensitive, thrombin-specific 276 
aptamer (Figure 2). In such system, depending on the pH, the P(AAm-co-AAc) hydrogel is present 277 
either in its deprotonated form, which is capable of swelling and absorbing water or protonated 278 
form, which results in expelling of the water and hydrogel contraction. Based on such volume 279 
changes, at pH 7.2, the aptamer-decorated microfins are able to protrude into the top solution, 280 
exposing a high affinity aptamer for thrombin binding, leading to its capture. In acidic conditions, the 281 
hydrogel contracts into the bottom layer and simultaneously the aptamer undergoes denaturation, 282 
resulting in the release of the captured thrombin molecules into the bottom fluidic layer. Future 283 
efforts should continue to address the need for cost-effective bioseparation processes, wherein on-284 
demand, fast reversibility of binding at the bio-interface can provide both high purity and high yield 285 
separations. Other notable features need to be kept in mind when developing future capture and 286 
release systems, namely their capability to selectively capture the target in complex biological 287 
medium and perform high-endurance switching cycles, while maintaining continuous high levels of 288 
performance. 289 
 290 
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 291 
Figure 2 - (A) Biphasic microfluidic chamber showing the capture of thrombin in the top channel 292 
using aptamer-decorated hydrogel P(Aac-co-Aam) microfins that swell at pH 7.2.7 (B) Thrombin is 293 
released in the bottom channel due to the contraction of the hydrogel at pH 3.2 and denaturation of 294 
the aptamer. 295 
 296 
4.3. In vitro and in vivo on-demand sensing 297 
 298 
On-demand specific capture of biomolecules on surfaces provides the opportunity for 299 
detecting only when required. Many different stimuli-responsive surfaces have been described that 300 
can be used for on-demand sensing, where different biomolecules, including proteins,  can be 301 
selectively immobilised by using electricity,53 temperature,30 and light50  as a stimulus. For instance, 302 
an electro-switchable surface based on the response of a charged molecular backbone on the 303 
structure of a mixed SAM can dramatically alter the specific binding activity of a surface-tethered 304 
ligand (biotin) to a protein (neutravidin) in solution.53 305 
While control over selective immobilization can be readily achieved, attaining reversibility of 306 
binding is not trivial. Overcoming such challenge opens the opportunity for developing reagentless, 307 
durable and reusable biosensors. In order to attain these capabilities, a PNIPAM polymer has been 308 
conjugated with an anti-cardiac troponin T (cTnT) antibody immobilised on a gold surface to mediate 309 
ON and OFF antibody binding.8 When PNIPAM is in a collapsed globular conformation at 37 °C, the 310 
recognition site of the antibody is exposed and available for binding, thus yielding the cTnT – anti-311 
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cTnT complex and an increase in Faradaic impedance at the sensing surface. By reducing the 312 
temperature to 25 °C, the PNIPAM adopts an extended coil conformation pushing the cTnT from the 313 
surface, allowing the regeneration of the immune-sensor. Despite its importance in the design of 314 
high-performance sensors, development of surfaces with effective temporary selective 315 
immobilization of biological entities and their release for reusability purposes is still in its infancy 316 
stage. Long-term switching capability and stability within complex biological environments (e.g. 317 
serum or blood) and signal amplification are certainly other crucial, but challenging, aspects at play 318 
in high performance sensing that have been barely investigated to date. Only when we meet these 319 
different capabilities, we will be able to witness their practical applicability in the real-time 320 
monitoring of biological processes in cell culture systems, biomarker detection for disease diagnosis 321 
or integration in medical devices or biomaterials for in vivo implantation. 322 
 323 
5. Tunable bioelectrocatalysis at the interface for in vitro, in situ and in vivo applications  324 
 325 
Aside from allowing capture and release of biomolecules, a further developed capability of 326 
stimuli-responsive surfaces is to enable manipulation of the activity of redox species. It can be used 327 
to reversibly activate and deactivate bioelectrocatalysis, establishing a novel foundation for 328 
construction of electrochemical biosensors and biofuel cells for use as, for example, on-demand 329 
power sources for implantable electronic devices.74 In such settings, it becomes essential to use an 330 
endogenous stimulus, in the form of, for instance, variations in physiological conditions, including 331 
concentration levels of biochemical substances (e.g. biomarkers). However, while feasibility has 332 
been demonstrated by transducing a biochemical input signal (e.g. urea and ethyl butyrate) into pH 333 
changes that activate/deactivate the bioelectrocatalytic glucose oxidation,75 there is still a long way 334 
to go to fully develop and utilise these internally regulated devices for long term in vivo operation. 335 
Fundamental aspects regarding selectivity, precise manipulation, reversibility and stability are yet to 336 
be investigated and from which future improvements and progress will evolve. 337 
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In addition to their impact on bioelectrochemical systems, signal-triggered 338 
bioelectrocatalysis may also provide the basis for the development of platforms for biocomputing, 339 
information storage and processing, and signal transduction and amplification.76 Over the past two 340 
decades, a variety of electrode surfaces have been devised that are able to control either the activity 341 
of electron mediators or redox enzymes by different stimuli, including light,77 magnetic field,78 342 
temperature,79 pH80 and mechanical stress.27 Recently, the unique physical and electrochemical 343 
properties of graphene nanosheets have been combined with the thermo-responsive polymer 344 
PNIPAM to mediate the activity of the immobilised enzyme cholesterol oxidase.79 The switchable 345 
sulfonated graphene-PNIPAM donor-acceptor interface acts as a zip, wherein hydrogen bonding 346 
creates a coalescence of the interface at 20oC that inhibits the diffusion of the substrate cholesterol 347 
for the catalytic enzyme reaction. At 40oC, the hydrogen bonding is broken, opening the zip with 348 
consequent increase in permeability and access of the cholesterol oxidase to its substrate. In 349 
another notable work, polyelectrolyte multilayer architectures have been fabricated that expose or 350 
conceal the enzyme alkaline phosphatase by mechanical stretching, in a similar manner to those 351 
mechanisms involved in proteins during mechanotransduction.27 352 
Further increase in complexity has been achieved by integrating dual-signal 353 
bioelectrocatalysis.9, 81 An emerging example is the generation of a triarm block copolymer, which 354 
contains the thermo-responsive PNIPAM and pH-sensitive poly-N,N-diethylaminoethylmethacrylate 355 
(PDEAEMA) units, for controlling the activity of the enzyme glucose oxidase (GOx). In the ON state 356 
(pH 4 and 20oC), the triarm block copolymer-based film with the embedded GOx is highly hydrophilic 357 
due to hydrogen bonding formation and, as a result, the enzyme can catalyse glucose due to its easy 358 
diffusion through the film. In the OFF state (pH 8 and 40oC), the overall polymer structure becomes 359 
hydrophobic, supressing the interaction between the enzyme and its substrate.  360 
Dual-signal bioelectrocatalysis has been also applied to build Boolean logic gates (i.e. “OR” 361 
and “AND”) based on enzymatic communications to deliver logic operations (Figure 3).9 This has 362 
been achieved by forming two graphene-based compartments, one containing acrylamide 363 
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copolymerised with light-responsive spiropyran methacrylate molecular units poly(Aam-co-SPMA) 364 
with embedded pyrroloquinoline quinone (PQQ)-dependent glucose dehydrogenase (GDH) and the 365 
other comprising a temperature-responsive amine-terminated PNIPAM assembled with cholesterol 366 
oxidase (ChOx). The graphene surfaces are initially modified with an anionic surfactant, sodium 367 
dodecyl benzene sulfonate to inhibit aggregation of the individual nanosheets and promote the 368 
assembly of the enzymes and responsive polymers. The catalytic activity of both compartments 369 
depends on the capability of the substrates to diffuse through the responsive films. In a similar 370 
manner as described for an example above,79 the mechanism in the temperature-responsive 371 
compartment relies on the reversible formation of hydrogen bonding between sulfonate groups of 372 
graphene and amino groups of the PNIPAM. In the case of the light-responsive compartment, the 373 
isomerisation of the spiropyran form into the merocyanine form (generated by UV irradiation) 374 
induces volume and polarity differences. While the spiropyran functionalised polymer forms a 375 
densely packed film, the charge-separated open-ring merocyanine functionalised polymer increases 376 
the permeability of the membrane, allowing the substrate to access the immobilised enzyme, thus 377 
facilitating electrobiocatalysis. An “OR” gate can be created by placing both compartments side by 378 
side, where either light or temperature can generate an electrochemical signal. If both 379 
compartments are on the top of each other, the system behaves as an “AND” gate, where an 380 
electrochemical signal is only generated when the substrates are allowed to diffuse through both 381 
compartments (UV light and 40oC). Stimuli-responsive interfaces have been driving and will continue 382 
to drive progress in the development of more complex biocatalytic and signal-processing systems, 383 
which not only have important technological implications but also provide new opportunities to 384 
elucidate electron-transport pathways and mechanisms in living organisms. We are though at the 385 
proof-of-concept stage and the interfacing of tunable bioelectrocatalysis systems with biological 386 
environments or coupling with living organisms are yet to be addressed. 387 
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 388 
 389 
Figure 3 - Schematic illustrating two different model systems, which allow building an “OR” gate 390 
(left) and an “AND” gate (right) using both temperature change and light irradiation. The truth table 391 
shows all the input and output possibilities.9 392 
 393 
 394 
6. Modulation and understanding of cell behaviour in vitro or in vivo settings 395 
 396 
Cell-ECM interactions are complex and comprise highly dynamic bidirectional processes. 397 
Cells interact with and respond to ECM cues and subsequently remodel their surroundings by 398 
applying forces or synthesizing and degrading ECM. Cell-ECM interactions are responsible for cellular 399 
processes such as adhesion, migration, survival and proliferation. Thus, understanding and 400 
harnessing the bidirectional communication between cell and ECM is essential in approaches to 401 
regenerate tissue structure and function as well as to regulate disease processes. Although the 402 
reproduction of all of these dynamic features in a synthetic system is currently out of reach, initial 403 
efforts in this direction have been taken and they rely mainly on the capability of controlling cell 404 
adhesion, proliferation and detachment events. Among other uses, scaffolds with such capabilities 405 
provide a mean of targeting in vivo loco-regional regeneration of damaged tissues, wherein the 406 
regeneration is regulated by a stimulus.82 407 
 408 
 409 
 410 
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6.1 Cell adhesion modulation via non-specific interactions 411 
 412 
Dynamic cell adhesion–detachment modulation has been accomplished by harnessing non-413 
specific interactions31 and specific interactions4 between cell membrane receptors, namely integrins 414 
and ECM proteins or short peptide sequences recognized by cell surface receptors. Stimuli-415 
responsiveness, targeting the formation and disruption of weak, non-specific interactions, has been 416 
mainly implemented to facilitate the capture of cells and their efficient release.31, 83, 84 Since 417 
circulating tumour cells are present in blood in low abundance, this approach is quite valuable for 418 
cancer cell enrichment, isolation and detection. With this proviso in mind, PNIPAM thermo-419 
responsive nanostructured surfaces have been developed to reversibly capture and release target 420 
cancer cells by combining switchable hydrophobic interactions and topographic interactions (Figure 421 
4A).31 In this example, silicon-nanopillars, which are modified with PNIPAM, allow 3D interfacial 422 
contact with the protrusions of the cancer cells, enhancing the cell-capture performance. At 37°C, 423 
the PNIPAM-coated silicon nanopillars attract a BSA-biotin conjugate via hydrophobic interactions. 424 
Cancer cells, which overexpress the epithelial cell adhesion molecule (EpCAM) on their surface, are 425 
then immobilised via streptavidin and a biotinylated anti-EpCAM antibody. At 20oC, the PNIPAM-BSA 426 
interactions are disrupted, causing desorption of the BSA-biotin conjugate and the release of highly 427 
viable cells. Aiming at the same application, pH-dependent reversible, covalent bonds between 428 
surface-tethered boronic acids and diols present in the carbohydrate chains of glycoproteins and 429 
glycolipids in the cell membrane can be taken advantage of to create a simplified responsive surface 430 
for capturing and releasing cancer cells, where surface recyclability is  possible.85 However, while 431 
boronic acids provide some selectivity for cancer cells, which display glycans at different levels or 432 
with fundamentally different structures than those observed on normal cells,  glycan specificity using 433 
such synthetic carbohydrate receptors is still  insufficient at this stage. 434 
 435 
 436 
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6.2 Cell adhesion modulation via specific interactions 437 
 438 
Non-specific interactions can be manipulated and exploited for regulating cell adhesion and 439 
detachment, but a finer control over cell behaviour can be reached by targeting the switching of 440 
specific interactions between material surfaces and cells. Whole ECM proteins are large, making 441 
them difficult to engineer or manipulate for incorporation in stimuli-responsive surfaces for 442 
controlling specific interactions. In contrast, peptide sequences can provide a simplified system, in 443 
which their functionality can be easily switched ON and OFF by applying an external stimulus. In this 444 
regard, the control of the activity of the surface-tethered cell adhesive peptide arginine-glycine-445 
aspartic acid (RGD) has been widely demonstrated using diverse stimuli, such as temperature,86, 87  446 
electrical potential,4, 56  and light.28, 88  The RGD sequence is the recognition site of a large number of 447 
adhesive ECM proteins, and a third of the integrin cell adhesion receptors are known to bind to this 448 
sequence. RGD sequence has been immobilised on various substrates, such as hydrogels,86  gold,4 449 
silicon,56 glass28 or quartz88 and shown to be modulated to promote or inhibit cell adhesion. Two 450 
main approaches have been followed to control cell adhesion using the RGD peptide. The first one 451 
consists on taking advantage of non-covalent interactions to capture the RGD peptide on the 452 
surface, thus promoting cell adhesion, which is then followed by the breakage of the non-covalent 453 
interactions using external stimulation to release the RGD peptide and, subsequently, the attached 454 
cells. The second approach relies on masking or unmasking the RGD peptide using stimuli-responsive 455 
components presented on the modified surface. In this scenario, small changes in the 456 
conformation/orientation of the RGD peptide on the surface are able to modulate the availability 457 
and potency of the RGD sites for cell surface receptors. 458 
Regarding the first approach, thermo-responsive recognition sites have been formed via 459 
molecular imprinting on PNIPAM-based hydrogels to specifically recognize the RGD peptide (Figure 460 
4B).86 The presence of PNIPAM allows that specific recognition sites are formed at 37oC but then 461 
disrupted at 20oC. Consequently, the collapse of the PNIPAM hydrogel at 37oC allows specific binding 462 
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of the RGD peptide and promotion of cell adhesion, while its swelling at 20oC triggers the release of 463 
the RGD peptide and subsequent cell detachment.  464 
 465 
Figure 4 - Illustration of two approaches for cell adhesion-detachment regulation. Both use the 466 
temperature-responsive hydrogel PNIPAM, which at high temperatures exhibits hydrophobic 467 
properties and it is presented in a collapsed morphology that excludes solvent, while at low 468 
temperatures it is hydrophilic and is presented in an extended, solvent-swelled conformation. (A) 469 
BSA-biotin conjugate works as an anchor between the cell and the PNIPAM via hydrophobic 470 
interactions contributing to cell attachment. Under an extended conformation, interactions between 471 
BSA and the hydrogel are disrupted, resulting on the release of the cells. (B) RGD molecules are 472 
molecular imprinted into the hydrogel providing cell attachment. The extension of the hydrogel 473 
changes the organization of the recognition sites, releasing RGD molecules and cells. 474 
 475 
 476 
In order to open the possibility for spatial control, capturing and releasing of the RGD peptide 477 
has been achieved by using azobenzene moieties to create reversible, self-assembled 478 
supramolecular host-guest systems on surfaces (Figure 5A).88 A surface-tethered α-cyclodextrin (α-479 
CD) is able to bind an azobenzene moiety functionalised with the RGD peptide (Azo-RGD) in the 480 
trans configuration, thus promoting cell attachment, while irradiation of the surface with UV light 481 
induces isomerization to the cis configuration, resulting in the release of Azo-RGD and cells. In this 482 
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and other examples,86, 88 cell detachment is accompanied by a simultaneous release of a RGD 483 
peptide derivative or other components from the surface. The integrity of the surface is sacrificed 484 
during the switching and the cells released bear non-natural cell-surface components. 485 
Ideally, control over cell adhesion and release should occur due to promotion and disruption of 486 
integrin-RGD interactions. With this purpose in mind, electrically-responsive surfaces, which open 487 
the opportunity for high level of spatial and temporal controllability, have been developed to 488 
manipulate the RGD accessibility to cells, taking advantage of charged molecular backbones4 or end 489 
groups.56 RGD exposure or concealment is based on the capability of it being protrude from or 490 
immersed into the non-adhesive background (e.g. oligo(ethylene glycol)) of a mixed monolayer. For 491 
instance, positively charged lysines have been functionalised with an end glycine-arginine-glycine-492 
aspartate-serine (GRGDS) recognition motif peptide and harnessed to induce its folding on the 493 
surface upon an application of a negative electrical potential (Figure 5B).4 These electrical-responsive 494 
surfaces are able to control cell adhesion by switching from a cell-resistant under a negative 495 
potential (RGD concealed) to a cell-adhesive (RGD exposed) state under open circuit conditions. 496 
Yet, the stimuli-responsive interface should have the capacity to control adhesion in a 497 
reversible manner in order to more closely recapitulate the dynamic cell-ECM interactions and 498 
enable innovative applications in cell engineering where transplantation could occur without the 499 
presence of a biodegradable scaffold. Towards this end, surface-immobilised RGD peptides have 500 
been developed that can be presented or shielded by the collapse or swelling of thermo-responsive 501 
polymer brush films based on 2-(2-methoxyethoxy)ethyl methacrylate (MEO2MA).87 Remarkably, 502 
the thermo-responsive surfaces allow disruption of the integrin-RGD interactions and release of the 503 
cells by a decrease in temperature from 37oC to 23oC. However, it is important to highlight that the 504 
effective disruption is dependent on the RGD surface density, where higher densities hinder cell 505 
detachment. The limitation is that a compromise needs to be found between high enough density to 506 
promote attachment and proliferation and low enough density for rapid cell release, preventing thus 507 
the desired high cell densities required in tissue engineering settings.  508 
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Photo-driven motions involving cis-trans isomerization of the azobenzene can be also employed 509 
to mask and unmask RGD peptide and regulate its interactions with cell-surface integrins using 510 
either polymer89 or SAM28, 90 surfaces. Interestingly, a RGD-coupled azobenzene mixed SAM can 511 
reversibly switch, to a certain extent, cell adhesion within a time scale of seconds as monitored by 512 
single-cell force spectroscopy (Figure 5C).28 During cycles of trans–cis–trans isomerization, the cells 513 
are shown to be more strongly attached to the RGD-coupled azobenzene mixed SAM under visible 514 
light (trans configuration) than under UV irradiation (cis configuration). More recently, push-pull-515 
substituted azobenzene molecules, which carry an electron withdrawing nitro substituent in one ring 516 
and an electron donating methyl group in the other ring, are coupled with integrin ligand c(RGDfK) 517 
headgroups to modulate cell adhesion via nanoscale oscillations.90 The presence of RGD push–pull 518 
azobenzene oscillations under continuous visible irradiation leads to a reinforcement of cell 519 
adhesion, which can be interpreted as the result of cell adhesion stimulation via mechanical forces. 520 
This is a very interesting example on stimuli-responsive surfaces, where molecular structured 521 
surfaces are being built to convert an initial macroscopic light stimulus into a nanomechanical 522 
stimulus to induce a cell response. 523 
 524 
Figure 5 - Representation of three approaches for cell adhesion-detachment regulation based on the 525 
availability of RGD on the surface. (A) is based on the capture and release of RGD, while (B) and (C) 526 
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are based on masking and unmasking of RGD. (A) The α-cyclodextrin captures the azobenzene in 527 
trans conformation, while releases it when in cis conformation. The capture and release of the RGD at 528 
the surface controls the cell adhesion and detachment, respectively. (B) Under open circuit, the 529 
extended conformation of the oligolysine allows RGD exposure, promoting cell adhesion. The 530 
positively charged oligolysine folds under a negative voltage, making the RGD unavailable for cell 531 
attachment. (C) The trans configuration of the azobenzene makes the RGD accessible to support cell 532 
adhesion, while the cis conformation conceals the RGD into the surrounding molecules.  533 
 534 
While peptide sequences are easy to manipulate, steps in the direction of developing stimuli-584 
responsive surfaces involving control over specific interactions between whole ECM proteins and cell 585 
membrane receptors have been taken. For instance, this behaviour has been achieved by combining, 586 
as in many emergent stimuli-responsive surface systems, switchable components with 587 
nanotopography. By incorporating nanopatterns within PNIPAM thermo-responsive polymer brush 588 
surfaces, fibronectin is able to selectively adsorb into the polymer free confined areas.91 The 589 
exposure of fibronectin at 37oC supports the attachment and proliferation of cells, while a reduction 590 
in temperature to 25oC allows their readily detachment. Although cellular detachment is shown not 591 
to deplete all fibronectin incorporated into the nanopatterned surface, the cell release is expected 592 
to be accompanied by fibronectin desorption. 593 
While proof-of-concept examples exist on the use of UV light to control cell adhesion, this type 594 
of stimulus can potentially cause cell and tissue damage. Thus, in order to prevent such negative side 595 
effects, NIR radiation has been investigated to modulate ECM protein-cell membrane receptor 596 
interactions and shown to control  cell detachment without affecting cellular integrity.54 This 597 
capability has been demonstrated by culturing mesenchymal stem cells on NIR-sensitive PEDOT-598 
coated substrates using serum-containing medium to promote their attachment and proliferation. 599 
Upon NIR exposure, stem cells are detached and shown to maintain their intrinsic characteristics as 600 
well as multilineage differentiation capacities. The disruption of the interactions between ECM 601 
proteins and integrin transmembrane receptors by heat generated from the photothermal effect of 602 
PEDOT is proposed to be responsible for the cell release. 603 
 604 
 605 
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6.3 Studies of cell behaviour 606 
 607 
In addition to their role in modulating cell adhesion and detachment, stimuli-responsive 608 
surfaces are also under investigation to regulate cell growth factor secretion92 and understanding 609 
the complex regulatory processes of cell migration.3, 19 In the latter, photoactivatable and well-610 
defined nanopatterned substrate provides the opportunity to precisely tune cell-substrate 611 
interactions in a spatiotemporal manner to analyse collective cell migration.3 The nanopatterned 612 
surface consists of gold nanoparticles that are arrayed in a regular manner with defined nanometer 613 
spacing and functionalised with cyclic RGD peptides and polyethylene glycol (PEG) moieties, which 614 
are linked to a glass substrate by photocleavable 2-nitrobenzyl ester moieties. PEG acts as a shielding 615 
layer, in which the RGD ligand only becomes available for promoting cell adhesion and migration 616 
when PEG is photocleaved by near-UV irradiation. On these nanopatterned surfaces, HeLa cells are 617 
first confined in photo-irradiated micro-regions, and then migration is promoted by a second 618 
photocleavage of the surrounding regions. In contrast to their collective migration behaviour on 619 
homogenous substrates, the HeLa cells are shown to change their migration phenotype and 620 
gradually lose their cell-cell contacts and become disconnected on the nanopatterned substrate. This 621 
study provides unprecedented evidence that cell-ECM interactions are an important factor 622 
regulating the decision of cells to migrate collectively or individually. Patterned electro-responsive 623 
surfaces can also be used to create a dynamic environment and trigger precise local cell migration. 624 
By employing the hydroquinone–quinone redox couple and electrochemically switching the cell-free 625 
regions from an inert to an adhesive migrating state, valuable insights into how initial pattern 626 
geometry and RGD ligand affinity and density affect migration velocity are being provided (Figure 627 
6).19 Interestingly, this study reveals a new behaviour of cell migration memory related with cells 628 
capability to remember their initial state, which influences their velocity and focal adhesion patterns 629 
when they move off from the initial adhesion location to newly formed RGD presenting regions. 630 
 631 
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 632 
 633 
Figure 6 - (A) Representation of an electro-responsive SAM for understanding cell mobility. Following 634 
oxidation of the hydroquinone into a reactive quinone, oxyamine-tethered RGD is immobilized on the 635 
surface, allowing real-time monitoring of cell migration. (B) Dynamic conditions, relatively to non-636 
dynamic, show a faster cell migration. (C) Fibroblasts under dynamic conditions show focal adhesion 637 
complexes (as shown in green by labelling the paxillin protein) that are more transient and localized at 638 
the periphery, compared with non-dynamic conditions where stable focal adhesion complexes are 639 
distributed throughout the cell body. Data reproduced from.19 640 
 641 
The first steps have been taken to develop switchable surfaces that can interact in a dynamic 642 
manner with cells, however the approaches are at research stage and limited to simple functions 643 
(e.g. regulate cell adhesion or detachment). In order to fully realise their potential for in vitro cell 644 
studies and as scaffolds for tissue engineering and regenerative medicine applications, more 645 
sophisticated stimuli-responsive interfaces, including with reversibility and multiple cues, are 646 
needed. They should more closely capture the complexity of the native ECM while also having the 647 
ability to work in complex biological media. The ability of scaffolds to regulate different biological 648 
cues at different times may open up the opportunity to drive stem cells toward specific fates93, 94 or 649 
promote particular cellular processes,  at different stages, in tissue development.95 650 
 651 
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7. Fine-tuning anti-bacterial effects for in vitro and in vivo settings 652 
 653 
Bacterial cells have propensity to colonize abiotic surfaces, resulting in the formation of 654 
structured, multicellular communities known as biofilms. Biofilms are often implicated in human 655 
infections, clogging of pipes, reduction of heat transfer in heat exchangers and cooling towers and 656 
fouling of ship hulls causing increased fluid resistance and fuel consumption. Since they affect 657 
adversely many human activities, prevention or eradication of biofilms has been a topic of intensive 658 
research over the past decades. Although progress has been made, our understanding of the 659 
molecular mechanisms of bacterial adhesion and biofilm formation is not completely unravelled and 660 
strategies are still subject to limitations in terms of their long-term resistance to bacterial adhesion. 661 
Bacterial adhesion and biofilm formation are intricately regulated by the interplay between bacteria 662 
and the abiotic surface, and thus, the emerging capability to provide abiotic surfaces with dynamic 663 
properties is opening up a whole new dimension of design possibilities to understand and combat 664 
biofouling. 665 
Non-specific interactions play a pivotal role in the initial phase of bacterial adhesion to 666 
material surfaces that eventually leads to the formation of biofilms. These interactions are reversible 667 
and stimuli-responsive surfaces have been introduced for their monitoring and regulation. To control 668 
the early stages of bacterial adhesion by electrically switching the physicochemical properties of the 669 
surface between an attractive (i.e. negatively charged surface) and a repellent (i.e. hydrophobic 670 
surface) state, well-defined, two-component SAMs comprising 11-mercaptoundecanoic-acid (MUA) 671 
and mercaptoethanol (MET) on gold have been designed and developed (Figure 7A).5 The MUA acts 672 
as the functional and switchable entity, whereby the MUA-containing SAM undergoes 673 
conformational changes upon attraction of the carboxylic acid charged end group to the substrate 674 
surface by an applied electrical potential. The reversible surface-reorganisation results in either 675 
straight chains with carboxylate anions exposed at the surface (i.e. negatively charged surface) or 676 
bent chains, exposing the alkyl chains at the surface (hydrophobic surface). By taking advantage of 677 
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the fast switching capability of the system (i.e. seconds), this dynamic platform is able to monitor in 678 
real-time the transition from reversible to irreversible bacterial adhesion, thereby providing a 679 
valuable tool for furthering our understanding of the mechanism underlying such relevant transition 680 
in biofilm development. Changes in the electrostatic properties of pH-responsive mixed polymer 681 
brushes consisting of positively charged polymers based on dimethylaminoethyl methacrylate and 682 
negatively charged polymers based on 3-acrylamidebenzene boronic acid have been also 683 
demonstrated to be suitable for reversibly switching the surfaces between bacteria-adherent and 684 
bacteria-resistant states within the first 30 minutes of incubation.96 Longer incubation times are not 685 
described, but a transition from a reversible to an irreversible state is expected for extended periods 686 
of incubation. 687 
If possible, dynamic, anti-bacterial surfaces should be devised that could permanently stop 688 
bacteria from reaching an irreversible state. Advances in this direction have been made by creating 689 
micro-wrinkling surfaces based on the elastomer PDMS that can be stretched and relaxed in 690 
response to mechanical strain (Figure 7B).6 Inspired by the mechanical frustration of sedentary 691 
marine organisms, commonly known as echinoderms, which present mobile, spiny microstructures 692 
to prevent the bio-fouling of their surfaces, the periodically wrinkled PDMS elastomer substrates 693 
undergo exposure to continuous cyclic mechanical stimulus to inhibit and dislodge bacteria that are 694 
reversibly bound to the surface. Significant reduction in bacterial attachment was obtained in the 695 
first day of culture, with a decline thereafter.  696 
While some research studies have been harnessing the reversible aspects of initial bacterial 697 
adhesion for actively mitigating biofouling, more intensive efforts have been focused on designing 698 
stimuli-responsive surfaces with multi-functionality for integrated biocidal activity and bacteria 699 
release.97 Conventional bactericidal surfaces can be quite effective at killing bacteria but they suffer 700 
from accumulation of dead bacteria, which not only degrades biocidal activity but also provides a 701 
conditioning layer for further bacterial attachment. Thus, it is desired to remove or release bacteria 702 
from the surface once they are killed to maintain long-term biocidal activity. Using mainly thermo-703 
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responsive polymers, such as PNIPAM,49 and pH-responsive polymers, such as PMAA,48 stimuli-704 
responsive surfaces have been developed that incorporate a kill and release strategy. In particular, 705 
the synergistic effects of combining nanotopography with stimuli-responsive polymers enable the 706 
construction of surfaces with effective biocidal and fouling-release functionalities.48, 49 In one 707 
example, silicon nanowire arrays modified with the PMAA pH-responsive polymer are able to serve 708 
as a reservoir for the controllable loading and release of a natural anti-microbial lysozyme (Figure 709 
7C).48 By switching step-wise the environmental pH, the nanostructured responsive surface is able to 710 
load the lyzozyme (pH 4), release it for bacteria killing (pH 7) and release dead bacteria (pH 10). 711 
While this and other examples illustrate how the introduction of stimuli-responsive mechanisms can 712 
lead to surfaces with enhanced anti-bacterial properties, there are still limitations in the current 713 
surfaces for on-demand killing and releasing of bacteria related to low cyclic capability. Effective 714 
switching performance is maintained over 2-3 cycles.48, 49, 98 Apart from the urge for anti-bacterial 715 
surfaces with faster killing and release mechanisms that can be performed over large number of 716 
times, their broader application is hampered by limited biocompatibility and requirement for multi-717 
step fabrication procedures.  718 
While different stimuli-responsive-based concepts have been investigated to prevent 719 
bacterial adhesion and biofilm formation, the long-term control is still out of reach. The challenges 720 
to achieve it depend on the extent to which effective dynamic properties can be maintained in the 721 
designed materials when those are exposed to the complex regulatory network systems in bacteria 722 
and their secreted compounds. This points to the importance of establishing design rules based on 723 
our understanding of sensing mechanisms and downstream cellular responses in bacteria. 724 
Therefore, the knowledge being generated in bacterial sensing mechanisms99-101 should play a more 725 
central role in guiding the future design of high performance anti-fouling materials. 726 
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 727 
Figure 7 - Representation of different approaches to control bacterial adhesion. (A) The applied 728 
voltage at the gold substrate repeals the anionic head group, allowing bacterial adhesion, or attracts it 729 
to the surface, forcing the bacteria out of the surface. (B) The PDMS surface treated with 730 
simultaneous O2 plasma and uniaxial stretching forms permanent wrinkles that under dynamic strain 731 
induce biofilm reduction. (C) The pH-responsive PMMA under acidic conditions allows the anti-732 
bacterial lysozome absorption in the interstitial spaces, while under neutral pH the deprotonated 733 
carboxilic acids release the lysozome, killing the bacteria. Under basic pH conditions, the full 734 
deprotonated PMMA becomes hydrophilic, resulting in the release of dead bacteria. 735 
  736 
8. Summary and outlook 737 
 738 
Controlling the interfacial chemical and physical properties to modulate biomolecule capture 739 
and release processes at engineered interfaces forms a crucial foundation for the development of 740 
on-demand biosensors, high-performance delivery systems and bioseparation platforms. Stimuli-741 
responsive capabilities are also opening the door to the development of highly complex 742 
bioelectrocatalytic systems,9 which are highly valuable for various technological applications and 743 
further our understanding of fundamental biocatalytic processes. The development of dynamic 744 
surfaces to control cell adhesion and detachment is paving the way for the design of cell culture 745 
supports in cell sheet engineering without the need for harsh cell releasing methods, such as 746 
enzymatic digestion or mechanical manipulation.83, 84  In addition to the impact in the production of 747 
cell sheets that can be used to repair or regenerate tissue, material surfaces with the capability to 748 
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dynamically modulate cell attachment and detachment are finding utility in the realms of cell 749 
enrichment and isolation for downstream detection of diseases31  and understanding fundamental 750 
mechanisms of cell adhesion and migration.19 Despite progress over recent years, application areas 751 
such as cell-based regenerative therapy would benefit from stimuli-responsive surfaces that would 752 
better meet, on one hand, rapid promotion of cell adhesion and proliferation, and on the other, 753 
rapid release of intact cells without affecting the underlying switchable adhesive matrix. Engineering 754 
of dynamic behaviour at the bio-interface for understanding fundamental cellular processes has only 755 
begun and significant efforts are still required to more closely recreate the complexity of the highly 756 
dynamic, multi-responsive three-dimensional ECM and incorporate the intricate feedback loops that 757 
exist in vivo between ECM and cells. 758 
To date, mainly due to the complexity of the adhesion process, anti-bacterial surfaces are 759 
not able to persistently resist bacteria attachment. Yet, important clues6, 102 are emerging. A mutual 760 
active and permanent interplay between bacteria and the abiotic surface is necessary to 761 
continuously inhibit and disrupt bacterial surface adhesion and growth. This requirement is well 762 
suited with the potential attributes that stimuli-responsive can possess, and thus, future research on 763 
the development of stimuli-responsive surfaces with long-term antibacterial efficiency are expected 764 
to embed more characteristics of continuous triggered actuation or autonomous adaptation. Surface 765 
materials with multi-functionalities are also highly desired, namely one that could effectively inhibit 766 
bacterial adhesion but concomitantly promote mammalian cell adhesion. 767 
Another central challenge in the field lies in the ability to translate the successful laboratory-768 
based systems to industrial or clinically useful systems. In order to address the current lack of 769 
translation, future material designs need to pay more attention to aspects such as long-lasting 770 
effective operation in vitro and in vivo, scalability and cost, in which simple-in-preparation and 771 
robust-in-operation should be carefully considered.  772 
The ground-breaking research we are witnessing today is only the first generation of 773 
dynamic bio-interfaces. It is anticipated that, in the future, bio-interfaces will exhibit superior 774 
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properties in terms of reversibility, multiple stimuli-responsiveness, reusability and adaptability to 775 
surrounding environments in order to address the current unmet biological, biotechnological and 776 
medical needs. Another opportunity that has so far remained overlooked is the possibility of 777 
harnessing stimuli not only to manipulate synthetic interfaces but directly biological or biologically 778 
derived interfaces or systems, including cells, tissues and organs. For instance, the design and 779 
engineering of biological systems with the inherent artificial ability to be tuned by an external 780 
stimulus opens unprecedented opportunities for spatial-temporal control over the system 781 
behaviour.103 The scope of opportunities in the field and impact is tremendous, wherein the use of 782 
stimuli-responsive mechanisms is poised to become an essential, integral component in the 783 
engineering of synthetic and biological materials and systems. 784 
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